
Sign up to save your podcasts
Or


Podcast moderator Lejla Vajzovic, MD, sits down with Robert L. Avery, MD; Carl D. Regillo, MD; and Durga S. Borkar, MD, MMCi, to explore how new therapies hold promise for extending treatment efficacy in patients with wet AMD. They touch on various drug delivery platforms, gene therapy, tyrosine kinase inhibitors, and the challenges of drug development and approval.
By Retina Today4.4
1818 ratings
Podcast moderator Lejla Vajzovic, MD, sits down with Robert L. Avery, MD; Carl D. Regillo, MD; and Durga S. Borkar, MD, MMCi, to explore how new therapies hold promise for extending treatment efficacy in patients with wet AMD. They touch on various drug delivery platforms, gene therapy, tyrosine kinase inhibitors, and the challenges of drug development and approval.

4,420 Listeners

43 Listeners

100 Listeners

2,455 Listeners

5 Listeners

4 Listeners

8 Listeners

21 Listeners

51 Listeners

11 Listeners

19 Listeners

0 Listeners

1 Listeners

19 Listeners

0 Listeners